| 发明名称 |
COMBINATION ANTI-CANCER THERAPY |
| 摘要 |
Methods and compositions for treating cancer comprising administering to a patient inhibitors of mT0RC1/C2, IGF-1 R, and IR. In some aspects, a combination of an mT0RC1/C2 inhibitor and an IGF-1 R/IR inhibitor is employed. Other aspects are described herein.
|
| 申请公布号 |
US2013005733(A1) |
申请公布日期 |
2013.01.03 |
| 申请号 |
US201113583396 |
申请日期 |
2011.03.09 |
| 申请人 |
OSI PHARMACEUTICALS, LLC;BARR SHARON;BUCK ELIZABETH A.;EPSTEIN DAVID M.;GOKHALE PRAFULLA C.;MIGLARESE MARK R. |
发明人 |
BARR SHARON;BUCK ELIZABETH A.;EPSTEIN DAVID M.;GOKHALE PRAFULLA C.;MIGLARESE MARK R. |
| 分类号 |
A61K31/53;A61K31/4985;A61P35/00;A61P35/04 |
主分类号 |
A61K31/53 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
